Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JAMA Network Open|April 24, 2026
Stroke and Bleeding Risks With Non-Vitamin K Oral Anticoagulants in Nonvalvular Atrial FibrillationMarie C Bradley, Andrew L Simon, Joy Kolonoski, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 2, 2024
Smaller Differences in the Comparative Effectiveness of Biologics in Reducing Asthma-Related Hospitalizations Compared With Overall ExacerbationsAyobami Akenroye, James Marshall, Andrew L Simon, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2019
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J L Heerspink, Tom Greene, Hocine Tighiouart, et al.
Inflammatory Bowel Diseases|June 26, 2023
Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative ColitisSruthi Adimadhyam, James D Lewis, Andrew L Simon, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2019
GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled TrialsLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.
The American Journal of Gastroenterology|December 12, 2022
Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's DiseaseMichael D Kappelman, Sruthi Adimadhyam, Laura Hou, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 18, 2020
Estimating total small solute clearance in patients treated with continuous ambulatory peritoneal dialysis without urine and dialysate collectionLi Fan, Dominik Steubl, Lesley A Inker, et al.
Kidney Medicine|August 1, 2020
Development and Validation of Residual Kidney Function Estimating Equations in Dialysis PatientsDominik Steubl, Li Fan, Wieneke M Michels, et al.
Pageof 2